Comparator Drug Sourcing Market Size, Share, Trends, & Industry Analysis Report By Type (Local Sourcing, Central Sourcing, and Market Sourcing), By Application, and By Region

Description

List of Tables

The comparator drug sourcing market size is expected to reach USD 2.22 Billion by 2034, according to a new study by Polaris Market Research. The report "Comparator Drug Sourcing Market Share, Size, Trends, Industry Analysis Report: By Type (Local Sourcing, Central Sourcing, and Market Sourcing), By Application, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Comparator drugs are essential in clinical trials to evaluate the safety and efficacy of new therapeutics against existing standards of care. These drugs are sourced through specialized providers that ensure regulatory compliance, batch traceability, and timely global delivery across trial sites.

Market growth is primarily driven by the rising number of global clinical trials globally coupled with growing regulatory scrutiny around drug traceability and quality compliance. Pharmaceutical sponsors and contract research organization (CROs) services are increasingly relying on sourcing partners that offer centralized and localized procurement models, ensuring supply continuity, documentation accuracy, and cross-border compliance.

Comparator Drug Sourcing Market Report Highlights

Based on type, the central sourcing segment dominated the market in 2024, owing to its ability to standardize procurement, improve regulatory compliance, and support large-scale Phase III clinical trials.

In terms of application, the contract manufacturing organizations (CMO) segment dominated the market in 2024. This is fueled by increasing trial outsourcing and the need for turnkey sourcing solutions within contract-based clinical execution.

North America accounted for the majority share of the global comparator drug sourcing market in 2024, fueled by high clinical trial volume, stringent FDA compliance requirements and strong reliance on centralized sourcing models.

Asia Pacific held significant market share, driven by expanding trial activity, cost advantages, and growing regional infrastructure.

A few global key market players include Thermo Fisher Scientific Inc., Clinigen Limited, Inceptua Group, Uniphar Clinical, Catalent, Inc, Clinical Services International (CSI), BAP Pharma Limited, Oximio, Bionical Emas, Alcura, Myonex, Cencora, Inc., Sharp Services, LLC, ADAllen Pharma, and RxSolutions division.

Polaris Market Research has segmented the market report on the basis of type, application, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Central Sourcing

Local Sourcing

Other Types

By Application Outlook (Revenue, USD Billion, 2020-2034)

Drug Producers/Manufacturers

Contract Manufacturing Organizations (CMO)

Academic and Research Institute

Other Applications

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM5971

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Comparator Drug Sourcing Market Insights

4.1. Comparator Drug Sourcing Market - Market Snapshot
4.2. Comparator Drug Sourcing Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Number of Global Clinical Trials
  - 4.2.1.2. Stringent Regulatory Requirements
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Operational Costs Associated with Temperature-Controlled Logistics
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Comparator Drug Sourcing Market Trends
4.6. Value Chain Analysis

5. Global Comparator Drug Sourcing Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
5.3. Central Sourcing
- 5.3.1. Global Comparator Drug Sourcing Market, by Central Sourcing, by Region, 2020-2034 (USD Billion)
5.4. Local Sourcing
- 5.4.2. Global Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
5.5. Other Types

6. Global Comparator Drug Sourcing Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
6.3. Drug Producers/Manufacturers
- 6.3.1. Global Comparator Drug Sourcing Market, by Drug Producers/Manufacturers, by Region, 2020-2034 (USD Billion)
6.4. Contract Manufacturing Organizations (CMO)
- 6.4.1. Global Comparator Drug Sourcing Market, by Contract Manufacturing Organizations (CMO), by Region, 2020-2034 (USD Billion)
6.5. Academic and Research Institute
- 6.5.1. Global Comparator Drug Sourcing Market, by Academic and Research Institute, by Region, 2020-2034 (USD Billion)
6.6. Other Applications
- 6.6.1. Global Comparator Drug Sourcing Market, by Other Applications, by Region, 2020-2034 (USD Billion)

7. Global Comparator Drug Sourcing Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Comparator Drug Sourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
7.3. Comparator Drug Sourcing Market - North America
- 7.3.1. North America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.3.2. North America: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.3.3. Comparator Drug Sourcing Market - U.S.
  - 7.3.3.1. U.S.: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.3.3.2. U.S.: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.3.4. Comparator Drug Sourcing Market - Canada
  - 7.3.4.1. Canada: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.3.4.2. Canada: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
7.4. Comparator Drug Sourcing Market - Europe
- 7.4.1. Europe: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.4.2. Europe: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.3. Comparator Drug Sourcing Market - UK
  - 7.4.3.1. UK: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.4.3.2. UK: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.4. Comparator Drug Sourcing Market - France
  - 7.4.4.1. France: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.4.4.2. France: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.5. Comparator Drug Sourcing Market - Germany
  - 7.4.5.1. Germany: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.4.5.2. Germany: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.6. Comparator Drug Sourcing Market - Italy
  - 7.4.6.1. Italy: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.4.6.2. Italy: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.7. Comparator Drug Sourcing Market - Spain
  - 7.4.7.1. Spain: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.4.7.2. Spain: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.8. Comparator Drug Sourcing Market - Netherlands
  - 7.4.8.1. Netherlands: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.4.8.2. Netherlands: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.9. Comparator Drug Sourcing Market - Russia
  - 7.4.9.1. Russia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.4.9.2. Russia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.4.10. Comparator Drug Sourcing Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.4.10.2. Rest of Europe: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
7.5. Comparator Drug Sourcing Market - Asia Pacific
- 7.5.1. Asia Pacific: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.3. Comparator Drug Sourcing Market - China
  - 7.5.3.1. China: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.5.3.2. China: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.4. Comparator Drug Sourcing Market - India
  - 7.5.4.1. India: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.5.4.2. India: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.5. Comparator Drug Sourcing Market - Malaysia
  - 7.5.5.1. Malaysia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.5.5.2. Malaysia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.6. Comparator Drug Sourcing Market - Japan
  - 7.5.6.1. Japan: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.5.6.2. Japan: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.7. Comparator Drug Sourcing Market - Indonesia
  - 7.5.7.1. Indonesia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.5.7.2. Indonesia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.8. Comparator Drug Sourcing Market - South Korea
  - 7.5.8.1. South Korea: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.5.8.2. South Korea: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.9. Comparator Drug Sourcing Market - Australia
  - 7.5.9.1. Australia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.5.9.2. Australia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.5.10. Comparator Drug Sourcing Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.5.10.2. Rest of Asia Pacific: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
7.6. Comparator Drug Sourcing Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.6.3. Comparator Drug Sourcing Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.6.4. Comparator Drug Sourcing Market - UAE
  - 7.6.4.1. UAE: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.6.4.2. UAE: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.6.5. Comparator Drug Sourcing Market - Israel
  - 7.6.5.1. Israel: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.6.5.2. Israel: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.6.6. Comparator Drug Sourcing Market - South Africa
  - 7.6.6.1. South Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.6.6.2. South Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.6.7. Comparator Drug Sourcing Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.6.7.2. Rest of Middle East & Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
7.7. Comparator Drug Sourcing Market - Latin America
- 7.7.1. Latin America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.7.3. Comparator Drug Sourcing Market - Mexico
  - 7.7.3.1. Mexico: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.7.3.2. Mexico: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.7.4. Comparator Drug Sourcing Market - Brazil
  - 7.7.4.1. Brazil: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.7.4.2. Brazil: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.7.5. Comparator Drug Sourcing Market - Argentina
  - 7.7.5.1. Argentina: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.7.5.2. Argentina: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
- 7.7.6. Comparator Drug Sourcing Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  - 7.7.6.2. Rest of Latin America: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Alcura
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. ADAllen Pharma
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. BAP Pharma Limited
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Bionical Emas
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Catalent, Inc.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Cencora, Inc.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Clinical Services International (CSI)
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Clinigen Limited
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Inceptua Group
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Myonex
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Oximio
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
9.12. RxSolutions division
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
9.13. Sharp Services, LLC
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
9.14. Thermo Fisher Scientific Inc.
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
9.15. Uniphar Clinical
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development